Webinar
Are you aware of the emerging strategies for managing early breast cancer at high risk of recurrence? Register your interest in this 1–hour EACCME® accredited*, independently-led, live webinar.
Managing risk of recurrence in early breast cancer – what’s on the horizon?
By clicking the "Sign Up" button you confirm you are happy to receive further information about this webinar and related Medthority updates.
Live Webinar Agenda
| Webinar Agenda Managing risk of recurrence in early breast cancer – what’s on the horizon? Thursday, 8th April 2021, 18:00-19:00 CET |
||
| Chair: Dr Gregory Vidal | ||
| Welcome and introduction | Dr Gregory Vidal (US) | 3 min |
| Session 1: The evolving treatment landscape for early breast cancer | Dr Gregory Vidal (US) | 12 min |
| Session 2: Risk stratification tools in early breast cancer | Professor Nadia Harbeck (Germany) | 15 min |
| Session 3: Emerging evidence for new strategies in treating high-risk early breast cancer | Professor Stephen Johnston (UK) | 15 min |
| Panel discussion and Q&A | All faculty | 15 min |
Add event to calendar
This concise and timely 1–hour EACCME® accredited* webinar brings you the unique opportunity to gain insight into one of the most exciting up-and-coming topics within early breast cancer care. Chaired by Dr Gregory Vidal, this webinar invites the medical researchers at the forefront of innovation in the early breast cancer field, including Professor Stephen Johnston and Professor Nadia Harbeck.
Keep up to date with emerging and future strategies for managing high-risk early breast cancer patients
Topics will cover the current and emerging treatment strategies for early breast cancer, with a focus on breast cancer patients who are at high risk of recurrence. Strategies for stratifying risk of recurrence will be shared, as well as the latest data highlighting the importance for risk stratification.
The webinar will additionally include a live panel discussion chaired by Dr Gregory Vidal, whereby your questions can be submitted to the faculty for consideration.
Faculty
Dr Gregory Vidal, MD, PhD
Dr Vidal is a medical oncologist at the West Cancer Center and Research Institute, and assistant professor at the University of Tennessee. Dr Vidal trained as a clinical researcher at the University of Stanford and is the recipient of multiple awards. He has also authored numerous research articles in journals including the New England Journal of Medicine, Lancet Oncology and Nature Communications.
Professor Nadia Harbeck, MD, PhD
Professor Harbeck is the head of the Breast Center, Oncological Therapy and Breast Clinical Trials Unit, Ludwig-Maximilians-University of Munich (LMU) based in Munich, Germany. She is a member of the expert panel issuing the yearly updated evidence-based Working Group for Gynecologic Oncology (AGO) Guidelines for breast cancer therapy in Germany, amongst other influential roles. Professor Harbeck has authored over 280 research articles in peer-reviewed journals.
Professor Stephen Johnston, MD, PhD
Professor Johnston is a medical oncologist at The Royal Marsden NHS Foundation Trust. He is also a professor of Breast Cancer Medicine and researcher at the Institute of Cancer Research, London. Professor Johnston has published over 250 breast cancer related articles in peer-reviewed journals, is a member of several scientific committees and advisory boards and serves as deputy/associate editor for the international journals ‘Breast Cancer Research’ and ‘Clinical Breast Cancer’.
To find out more on breast cancer management, visit our Learning Zone where you will also find expert interviews, interactive patient case studies, publication digests and congress highlights.
* The EACCME® application for this Webinar agenda has been submitted, and is awaiting approval.
of interest
are looking at
saved
next event
This content has been developed independently of the sponsor, Lilly, which has had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.